iRhythm Technologies, Inc. – NASDAQ:IRTC

Add to watchlist

$158.22

+69.42

+78.18%

Market closed

Open in 2 days

-7.68%

month

-7.68%

quarter

-18.54%

year

Market Cap	2.74B
Enterprise value	4.05B

P/E	-34.23
EV/Sales	9.87
EV/EBITDA	-44.03
Price/Sales	9.74
Price/Book	16.70
PEG ratio	2.81
EPS	-4.23

Revenue	513.17M
EBITDA	-91.27M
Income	-129.96M
Revenue Q/Q	18.38%
Revenue Y/Y	19.34%

Profit margin	-28.27%
Oper. margin	-21.21%
Gross margin	68.54%
EBIT margin	-21.21%
EBITDA margin	-17.79%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

iRhythm Technologies Stock Forecast

M Q Y

Last Year

$108.11

Potential downside: -31.67%

Analysts Price target
Financials & Ratios estimates

iRhythm Technologies, Inc. (NASDAQ:IRTC): Profit margin
Jun 2023	124.13M	-18.48M	-14.89%
Sep 2023	124.60M	-27.11M	-21.76%
Dec 2023	132.51M	-38.69M	-29.2%
Mar 2024	131.92M	-45.66M	-34.61%

iRhythm Technologies, Inc. (NASDAQ:IRTC): Debt to assets
Jun 2023	429488000	205.60M	47.87%
Sep 2023	439769000	219.97M	50.02%
Dec 2023	433144000	223.04M	51.49%
Mar 2024	909755000	819.46M	90.08%

iRhythm Technologies, Inc. (NASDAQ:IRTC): Cash Flow
Jun 2023	-4.57M	9.00M	4.38M
Sep 2023	1.19M	-15.43M	66K
Dec 2023	-15.97M	1.4M	3.46M
Mar 2024	-52.02M	39.99M	504.64M

iRhythm Technologies alternative data

iRhythm Technologies
Employees

iRhythm Technologies, Inc. (NASDAQ:IRTC): Employee count
Aug 2023	1,793
Sep 2023	1,793
Oct 2023	1,793
Nov 2023	1,793
Dec 2023	1,793
Jan 2024	1,793
Feb 2024	1,793
Mar 2024	2,000
Apr 2024	2,000
May 2024	2,000
Jun 2024	2,000
Jul 2024	2,000

iRhythm Technologies
Hedge Funds Holdings Q3 2022

91.21% -8.79%

of IRTC is owned by hedge funds

204 -31

hedge funds hold IRTC stock

27.22M -2.48M

shares is hold by hedge funds

IRTC hedge funds holdings changes

iRhythm Technologies
Insider Trading

iRhythm Technologies, Inc. (NASDAQ:IRTC): Insider trades (number of shares)
Period	Buy	Sel
Jan 2024	0	7218
Feb 2024	0	35052
Mar 2024	0	15590
Jun 2024	0	1641
Jul 2024	0	1404
Aug 2024	0	5072
Nov 2024	6664	16145
Dec 2024	0	2492

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	2 Dec 2024	MURPHY PATRICK MICHAEL officer: CBO and CLO officer: CBO and CLO	Common Stock	2,492	$85.89	$214,038
Purchase	4 Nov 2024	TALWALKAR ABHIJIT Y director director	Common Stock	6,664	$75.16	$500,866
Sale	4 Nov 2024	BLACKFORD QUENTIN S. director, officer: President and CEO director, officer: President an..	Common Stock	16,145	$77.41	$1,249,784
Sale	9 Aug 2024	BOBZIEN BRICE officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock	1,372	$70.34	$96,506
Sale	2 Aug 2024	PATTERSON CHAD officer: Chief Commercial Officer officer: Chief Commercial Officer	Common Stock	3,012	$74.66	$224,876
Sale	2 Aug 2024	SMITH MERVIN officer: EVP Strategic Business Ops officer: EVP Strategic Business..	Common Stock	688	$74.66	$51,366
Sale	2 Jul 2024	TURAKHIA MINANG officer: EVP, CMO & CSO officer: EVP, CMO & CSO	Common Stock	1,404	$105.65	$148,333
Sale	3 Jun 2024	ROSENBAUM MARC W. officer: Chief Accounting Officer officer: Chief Accounting Officer	Common Stock	510	$88.91	$45,344
Sale	3 Jun 2024	SHRISHRIMAL SUMI officer: EVP, Chief Risk Officer officer: EVP, Chief Risk Officer	Common Stock	1,131	$88.91	$100,557
Sale	4 Mar 2024	DAY MARK J. officer: Chief Te..	Common Stock	3,248	$111.14	$360,983

IRTC insider trading transactions

Status	Patent	Filling date	Issue date
Grant	Grant Utility: Non-invasive cardiac monitor and methods of using recorded cardiac data to infer a physiological characteristic of a patient Filling date: 14 Feb 2022 Issue date: 12 Jul 2022	14 Feb 2022	12 Jul 2022
Grant	Grant Utility: Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network Filling date: 18 Feb 2022 Issue date: 5 Jul 2022	18 Feb 2022	5 Jul 2022
Grant	Grant Utility: Wearable device with bridge portion Filling date: 6 Aug 2021 Issue date: 7 Jun 2022	6 Aug 2021	7 Jun 2022
Grant	Grant Utility: Adhesive physiological monitoring device Filling date: 6 Aug 2021 Issue date: 7 Jun 2022	6 Aug 2021	7 Jun 2022
Application	Application METHODS AND SYSTEMS FOR PROCESSING DATA VIA AN EXECUTABLE FILE ON A MONITOR TO REDUCE THE DIMENSIONALITY OF THE DATA AND ENCRYPTING THE DATA BEING TRANSMITTED OVER THE WIRELESS NETWORK Filling date: 18 Feb 2022 Issue date: 2 Jun 2022	18 Feb 2022	2 Jun 2022
Application	Application WEARABLE DEVICE WITH CONDUCTIVE TRACES AND INSULATOR Filling date: 14 Feb 2022 Issue date: 26 May 2022	14 Feb 2022	26 May 2022
Grant	Grant Utility: Electrical components for physiological monitoring device Filling date: 6 Aug 2021 Issue date: 24 May 2022	6 Aug 2021	24 May 2022
Grant	Grant Utility: Wearable monitor Filling date: 7 Dec 2021 Issue date: 29 Mar 2022	7 Dec 2021	29 Mar 2022
Application	Application WEARABLE MONITOR Filling date: 7 Dec 2021 Issue date: 24 Mar 2022	7 Dec 2021	24 Mar 2022
Grant	Grant Utility: Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network Filling date: 9 Aug 2021 Issue date: 22 Feb 2022	9 Aug 2021	22 Feb 2022

iRhythm Technologies
Earnings Call Transcripts

Quarter	Transcript
Q1 2024 2 May 2024	Q1 2024 Earnings Call Transcript
Q4 2023 22 Feb 2024	Q4 2023 Earnings Call Transcript
Q3 2023 2 Nov 2023	Q3 2023 Earnings Call Transcript
Q2 2023 3 Aug 2023	Q2 2023 Earnings Call Transcript

IRTC earnings call transcripts

iRhythm Technologies
Executives

Insider	Age	Compensation
Mr. Kevin M. King (1956) Consultant & Director	69	$1,390,000
Mr. Douglas J. Devine (1970) Chief Operating Officer, Chief Financial Officer & Sec.	55	$573,160
Mr. David A. Vort (1966) Executive Vice President of Sales & Chief Commercial Officer	59	$552,100
Mr. Mark J. Day Ph.D. (1971) Executive Vice President of R&D	54	$538,430

iRhythm Technologies
Latest News

Sunday, 29 December 2024
10:00	Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation	accesswire.com
Thursday, 26 December 2024
10:00	Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation	accesswire.com
Sunday, 22 December 2024
10:00	Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation	accesswire.com
Wednesday, 18 December 2024
10:00	Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out	accesswire.com
Sunday, 15 December 2024
10:00	Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach Out	accesswire.com
Friday, 13 December 2024
08:08	Top 3 Robotics and Automation Stocks for the Next AI Boom	marketbeat.com
Wednesday, 11 December 2024
16:00	Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect	accesswire.com
Tuesday, 3 December 2024
05:44	iRhythm resumed with an Equal Weight at Wells Fargo	https://thefly.com
Wednesday, 20 November 2024
16:30	iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference	globenewswire.com
Monday, 18 November 2024
08:15	iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring	globenewswire.com
Tuesday, 5 November 2024
16:30	iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference	globenewswire.com
Friday, 1 November 2024
21:00	IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	globenewswire.com
Wednesday, 30 October 2024
20:26	iRhythm Technologies, Inc. (IRTC) Q3 2024 Earnings Call Transcript	seekingalpha.com
19:36	IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates	zacks.com
17:15	iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device	globenewswire.com
16:08	iRhythm Technologies Announces Third Quarter 2024 Financial Results	globenewswire.com
Monday, 28 October 2024
08:02	Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy	globenewswire.com
Wednesday, 23 October 2024
08:50	iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?	zacks.com
Tuesday, 22 October 2024
13:18	With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says	benzinga.com
12:41	iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT	zacks.com
Monday, 21 October 2024
16:05	iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device	globenewswire.com
Wednesday, 16 October 2024
16:05	iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024	globenewswire.com
Friday, 20 September 2024
08:00	Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm	globenewswire.com
Friday, 13 September 2024
11:55	iRhythm's Zio ECG System Gets Approval in Japan, Stock Falls	zacks.com
Wednesday, 11 September 2024
08:05	iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence	globenewswire.com
Tuesday, 10 September 2024
13:14	iRhythm Stock Gains Following Favorable Zio Monitor Study Data	zacks.com
Monday, 9 September 2024
12:01	iRhythm Stock May Gain on Its Latest Deal With BioIntelliSense	zacks.com
08:05	iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting	globenewswire.com
Sunday, 1 September 2024
13:33	iRhythm Technologies Announces Results of GUARD-AF Trial	globenewswire.com
Friday, 30 August 2024
12:21	iRhythm Technologies Launches Zio Monitoring Across Europe	zacks.com

Ideas & Opinions

Seeking Alpha 13 Jul 2023

iRhythm Technologies: Unpacking The FDA Warning Letter
Seeking Alpha 26 May 2023

iRhythm: Revolutionizing Arrhythmia Detection With AI And Machine Learning
Seeking Alpha 26 Apr 2023

iRhythm: AI Products May Be Better Than Cardiologists And Stock Looks Cheap
Seeking Alpha 8 Jun 2022

iRhythm: Reimbursement Overhang Squashed, Bull Thesis Back Intact
Seeking Alpha 23 Sep 2021

iRhythm: Upside Potential If Reimbursement Issues Can Be Resolved
Seeking Alpha 17 May 2021

Biotricity: Equipping Doctors, Empowering Patients, Enriching Shareholders

Frequently Asked Questions (FAQ)

What's the price of iRhythm Technologies stock today?

One share of iRhythm Technologies stock can currently be purchased for approximately $158.22.
When is iRhythm Technologies's next earnings date?

Unfortunately, iRhythm Technologies's (IRTC) next earnings date is currently unknown.
Does iRhythm Technologies pay dividends?

No, iRhythm Technologies does not pay dividends.
How much money does iRhythm Technologies make?

iRhythm Technologies has a market capitalization of 2.74B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 19.9% to 492.68M US dollars.
What is iRhythm Technologies's stock symbol?

iRhythm Technologies, Inc. is traded on the NASDAQ under the ticker symbol "IRTC".
What is iRhythm Technologies's primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of iRhythm Technologies?

Shares of iRhythm Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are iRhythm Technologies's key executives?
iRhythm Technologies's management team includes the following people:
- Mr. Kevin M. King Consultant & Director(age: 69, pay: $1,390,000)
- Mr. Douglas J. Devine Chief Operating Officer, Chief Financial Officer & Sec.(age: 55, pay: $573,160)
- Mr. David A. Vort Executive Vice President of Sales & Chief Commercial Officer(age: 59, pay: $552,100)
- Mr. Mark J. Day Ph.D. Executive Vice President of R&D(age: 54, pay: $538,430)
How many employees does iRhythm Technologies have?

As Jul 2024, iRhythm Technologies employs 2,000 workers.
When iRhythm Technologies went public?

iRhythm Technologies, Inc. is publicly traded company for more then 8 years since IPO on 20 Oct 2016.
What is iRhythm Technologies's official website?

The official website for iRhythm Technologies is irhythmtech.com.
Where are iRhythm Technologies's headquarters?

iRhythm Technologies is headquartered at 699 8th Street, San Francisco, CA.
How can i contact iRhythm Technologies?

iRhythm Technologies's mailing address is 699 8th Street, San Francisco, CA and company can be reached via phone at +41 56325700.
What is iRhythm Technologies stock forecast & price target?

Based on 8 Wall Street analysts` predicted price targets for iRhythm Technologies in the last 12 months, the avarage price target is $108.11. The average price target represents a -31.67% change from the last price of $158.22.

iRhythm Technologies, Inc.

irhythmtech.com

Exchange:

NASDAQ

Full time employees:

2,000

Industry:

Medical - Devices

Sector:

Healthcare

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

+41 56325700

699 8th Street
San Francisco, CA 94103

CIK: 0001388658
ISIN: US4500561067
CUSIP: 450056106